Skip to main content

Table 4 Risk factors for persistent/recurrent anemia (group C)

From: The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study

Risk factors

Univariate analysis

P

Multivariate analysis

P

OR (95% CI)

OR (95% Cl)

Female sex

1.32 (0.97–1.79)

0.0804

0.78 (0.56–1.10)

0.1555

CD diagnosis

1.59 (1.16–2.19)

0.0044

0.77 (0.54–1.10)

0.1519

Median IBD duration

1.0304 (1.01–1.05)

0.0100

1.03 (1.00–1.05)

0.0259

Median diagnosis age

0.9971 (0.99–1.01)

0.5563

  

Active smokers

1.04 (0.75–1.45)

0.8113

  

CRP > 3 mg/dl

1.11 (0.79–1.56)

0.5512

  

Extensive colitis

1.28 (0.76–2.14)

0.3568

  

Penetrating or stricturing CD

2.07 (1.40–3.07)

0.0003

  

Ileocolonic

1.09 (0.74–1.61)

0.6464

  

EIMs

1.82 (1.33–2.49)

0.0002

1.79 (1.27–2.52)

0.0008

Major disease surgeries

2.15 (1.43–3.23)

0.0002

1.73 (1.07–2.78)

0.0257

IBD hospitalizationsa

2.39 (1.56–3.66)

0.0001

1.96 (1.25–3.09)

0.0035

Immmunomodulators

1.20 (0.89–1.64)

0.2346

  

Anti-TNF any time

1.53 (1.11–2.12)

0.0090

0.79 (0.55–1.14)

0.2062

Other biologics at any time

1.48 (0.82–2.68)

0.1944

  
  1. CD, Crohn’s Disease; IBD, Inflammatory Bowel Disease; CRP, C-Reactive Protein; EIMs, Exta-intestinal Manifestations; Anti-TNFs, Anti-Tumor Necrosis Factors
  2. aIBD hospitalizations n = 5 the last 5 years